Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,333 recruiting studies in this area right now.
By phase
- Not applicable4,394
- Phase 2610
- Phase 1412
- Phase 3321
- Phase 4272
- Phase 1/Phase 2254
- Phase 2/Phase 370
Top conditions
- Ovarian Cancer338
- Cervical Cancer232
- Endometrial Cancer207
- Bladder Cancer189
- Acute Kidney Injury139
- Endometriosis134
- Chronic Kidney Diseases131
- Pregnancy131
- Breast Cancer108
- Chronic Kidney Disease106
- Infertility94
- Renal Cell Carcinoma81
- Colorectal Cancer74
- Preeclampsia73
- Pregnancy Related72
- Prostate Cancer65
- Pregnancy Complications64
- Urinary Incontinence63
Leading sponsors
- Mayo Clinic59
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS48
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- Assistance Publique - Hôpitaux de Paris46
- M.D. Anderson Cancer Center45
- National Cancer Institute (NCI)41
- University of Colorado, Denver39
- Chinese University of Hong Kong38
- University of Aarhus36
- AstraZeneca35
Where studies are running
- California346
- Alabama155
- Texas121
- Massachusetts119
- New York117
- Florida103
- Arizona100
- Colorado90
- Maryland89
- Illinois78
Recruiting studies6,333 total
- NCT07294859Recruiting
Ultrasound to predict kidney function after kidney removal
This trial uses special ultrasound techniques to predict how well your remaining kidney will work after surgery to remove part or all of one kidney. It may help doctors understand your recovery and tailor follow-up care.
Nanjing, JiangsuAges 18 years+ - NCT07295106Recruiting
Personalized music therapy for preterm babies
This trial tests whether specially selected music can help preterm infants in the NICU. It aims to improve their comfort and development during their hospital stay.
Perugia, PGAges 5 days–2 weeks - NCT07295808Recruiting
Study of IgA antibodies in kidney disease
This study looks at a specific type of antibody called IgA in patients with certain kidney diseases. It aims to understand which IgA antibodies cause kidney damage, which could help develop better treatments.
LimogesAges 18 years+ - NCT07295782Recruiting
Blood clotting study for women after pelvic surgery
This study looks at how blood clots form in women who have had surgery for uterine prolapse or urine incontinence after medication didn't work. It may help doctors understand bleeding and clotting risks after these procedures.
Krakow, MałopolskaAges 18–70 - NCT07296419Recruiting
Fetal oxygen monitor study for laboring mothers
This study tests a new device that measures oxygen levels in babies during labor. It may help doctors monitor your baby's health more closely if you are in labor and have an epidural.
Shreveport, LouisianaAges 18 years+ - NCT07296835Recruiting
Comparing a new flexible ureteroscope for kidney stone surgery
This trial tests a specific flexible scope (Shenzhen HugeMed 6.3 French) for removing kidney or ureter stones. It looks at how well it works, costs, and recovery, and may be a good option if you have stones smaller than 2.5 cm and need your first such surgery.
Kansas City, KansasAges 18 years+ - NCT07297953Recruiting
Access sheaths and stents study for kidney stone treatment
This study looks at the use of a ureteral access sheath (a tube that helps the surgeon reach the kidney) in people who already have a ureteral stent (a small tube placed in the ureter) and are having a stone removal procedure called ureteroscopy. It aims to find out if using this sheath is helpful for treating stones in the kidney or ureter.
Ann Arbor, MichiganAges 18 years+ - NCT07298564Recruiting
Magnesium and levocarnitine for PCOS symptoms
This trial tests whether taking magnesium and levocarnitine (a natural substance that helps cells make energy) can improve metabolism and reduce symptoms like irregular periods or weight gain in women with polycystic ovary syndrome (PCOS). If you have PCOS, you may be able to join.
Tehran, Tehran ProvinceAges 19–65 - NCT07298642RecruitingPhase 2/Phase 3
Proton therapy for advanced cervical cancer
This trial tests a type of advanced radiation called proton therapy that targets a larger area of the pelvis and abdomen for cervical cancer. It may be an option if your cancer has spread to nearby lymph nodes and you haven't had radiation before.
TaipeiAges 20–85 - NCT07299357Recruiting
Radiation therapy for small kidney tumors
This trial tests a precise type of radiation therapy for small, early-stage kidney tumors that cannot be surgically removed or are at high risk for surgery. It aims to offer an alternative treatment with fewer side effects.
Milan, MilanAges 18 years+ - NCT07301827Recruiting
New PET imaging for kidney cancer diagnosis
This study tests a new kind of PET scan that might better detect kidney cancer. It involves an injection of a special imaging agent and a scan to see if the cancer shows up clearly.
Wuhan, HubeiAges 18 years+ - NCT07303387RecruitingPhase 2
Valemetostat for solid tumors with SWI/SNF gene changes
This trial tests a new drug, valemetostat, for solid tumors that have specific genetic changes (like loss of SMARCB1, SMARCA4, or ARID1A). It is for people whose cancer has continued to grow despite other treatments. The study will see if valemetostat can help shrink or slow tumors.
Villejuif, Val de MarneAges 18 years+ - NCT07303725Recruiting
Spectral CT scan during cancer tumor treatment
This study tests a special CT scan used during procedures to treat tumors, like blocking blood flow or burning the tumor. It may help doctors see tumors more clearly during the treatment.
Palo Alto, CaliforniaAges 18 years+ - NCT07303894RecruitingPhase 2
Isoquercetin for ovarian cancer patients
This trial tests if a plant-based supplement called isoquercetin can help people with ovarian cancer when given alongside their first chemotherapy. It aims to see if it improves treatment results.
Boston, MassachusettsAges 18 years+ - NCT07304128RecruitingPhase 1
PLB-002 for advanced solid tumors study
This trial tests a new drug called PLB-002 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective, especially for cancers that show a specific marker called CLDN6.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07305116RecruitingPhase 1
CAR T-cell therapy for autoimmune diseases
This trial tests a new immune therapy called CAR T-cells that target two proteins (CD19 and BCMA) to treat autoimmune diseases like lupus, nephrotic syndrome, and others. It is for people whose standard treatments have not worked well enough.
Hangzhou, ZhejiangAges 3 years+ - NCT07305519Recruiting
Can supplements prevent early birth for short cervix?
This study tests if taking a combination of magnesium, a natural supplement (palmitoylethanolamide), hyaluronic acid, and vitamins B6 and D can help prevent preterm birth in women with a shorter-than-ideal cervix.
Rome, RMAges 18 years+ - NCT07305727Recruiting
Can MRI scans help predict chemo-radiation success in cervical cancer?
This trial uses MRI scans taken before treatment to see if they can predict how well chemo-radiation will work for locally advanced cervical cancer. It aims to help doctors know which patients might benefit most from this therapy.
Nîmes, GardAges 18 years+ - NCT07305974RecruitingPhase 2
Study of RG002C0106 for primary IgA nephropathy
This phase 2a trial tests an experimental drug called RG002C0106 in people with primary IgA nephropathy. The goal is to see if the drug can reduce protein in the urine and protect kidney function.
Beijing, Beijing MunicipalityAges 18–65 - NCT07306676Recruiting
PTSD after early miscarriage
This study looks at post-traumatic stress after a miscarriage that happens early in pregnancy (up to 14 weeks). It aims to understand how people feel emotionally and mentally after this experience.
Krakow, MalopolskaAges 18–45 - NCT07306689Recruiting
PTSD after ectopic pregnancy
This study looks at whether people who have had an ectopic pregnancy (a pregnancy outside the womb) might experience posttraumatic stress disorder (PTSD). It aims to understand emotional impacts and may help improve care.
KrakowAges 18–45 - NCT07306793Recruiting
Mouth care and meal timing for preterm infants ready to eat
This study tests whether a gentle mouth care routine combined with a special feeding schedule helps preterm babies start eating by mouth more quickly and gain weight. It is designed for stable preterm infants born at 29-33 weeks.
AydinAges 7 months–8 months - NCT07306819Recruiting
Two kidney stone removal methods compared
This study compares two ways to remove kidney stones: mini-PCNL (a small incision in your back) versus flexible ureteroscopy with a suction sheath (a tube through the urinary tract). It aims to find which method works better and is safer for stones of this size.
CairoAges 18 years+ - NCT07307365Recruiting
Test for early labor risk in pregnant women
This trial tests a new kit (PremaSure) to see if it can accurately predict which pregnant women with early labor symptoms are at risk of delivering prematurely. It aims to help doctors make better decisions about monitoring and care.
Lausanne, Canton of VaudAges 18 years+
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,333 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 10,314 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.